Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Hits & Misses
    • Artificial Intelligence and Healthcare
    • Doctors & Hospitals
      • COVID-19 and Public Health
    • Policy & Legislation
      • Affordable Care Act
    • Health Economics & Costs
      • Cost of Healthcare
      • Drug Prices & Regulations
      • Health Reform
    • Health Insurance
      • Public Insurance
      • Medicare
    • Telemedicine
      • Medical Tourism
  • Goodman Institute
  • Contact
  • Search
The Goodman Institute Health Blog

Category: News and Events

Thursday Links – 26 March 2026

Posted on March 26, 2026 by John C. Goodman
  • Study: A 10 percentage point increase in Medicare Advantage penetration is associated with a 1.5% decrease in total Medicare spending.
  • CBO data: “Despite historically unprecedented economic gains for low-income Americans, more of them are dependent on government assistance than at any point in the country’s history.”
  • Red states are gaining population. “Conspicuous among the losers are Illinois, California, and New York – a trifecta of big government, big government spending, and high taxes.”
  • UnitedHealthcare now gets more than three-quarters of its revenues from Uncle Sam, even though it covers almost twice as many people in its private, commercial plans sunce the onset of Obamacare.
  • What if AI could not only diagnose, but also write prescriptions? (Forbes)
  • Delta: members of Congress no longer get to skip the  TSA waiting lines.  (Forbes)
+

Ozempic’s Patent is Expiring Around the World, but Not in U.S.

Posted on March 26, 2026March 24, 2026 by Devon Herrick

Ozempic and Wegovy (both Semaglutide) recently lost patent protection in countries where 40% of the world’s population live. The list includes India, China, Turkey, Canada, South Africa, and Brazil. Thus, a drug which most of these countries’ population could not afford may now have access to a weight-loss drug for as little as $15 a month. The price is speculative, firm prices are not yet known but will likely fall over time as more competitors begin to produce the drug.

+

Wednesday Links – 25 March 2026

Posted on March 25, 2026 by John C. Goodman
  • Coffee appears to be good for the brain.
  • Congress: release the Epstein files, but don’t release any reports on our own misbehavior.
  • Jerome Powell: “there’s zero net job creation in the private sector” over roughly the past six months.
  • Is Elon going to pay TSA salaries? 
  • Yglesias: “the number one thing that I wish people understood about K-12 education in the United States is that while the [No-Child-Left-Behind] regime was in place, our schools got better.”
+

Congress will get its vote on the war with Iran

Posted on March 24, 2026 by Merrill Matthews

It appears Congress will finally get to vote on President Trump’s self-initiated war with Iran. It won’t be a direct vote on the war, even though Article I of the U.S. Constitution vests that power in Congress and not the executive branch. It will be an indirect vote providing funding for the war effort and replenishing our munitions — and perhaps other items.

+
  • Previous
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 488
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 42 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom